Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Genomics group gets $75m capital injection

    By HE WEI in Shanghai | China Daily | Updated: 2017-05-03 08:10
    Share
    Share - WeChat

    WuXi NextCODE, a contract genomics company headquartered in Shanghai, announced on Tuesday that it received a $75 million capital injection, as China targets precision medicine using gene sequencing as a new focus for improving health and medical standards.

    The fresh financing is being led by Yunfeng Capital, a fund backed by billionaire Jack Ma, chairman of Alibaba Group Holding Ltd, and Singaporean investment firm Temasek Holdings Pte, WuXi NextCODE said in a statement.

    The company said it will use the proceeds from this round of financing to advance the commercialization of its consumer solutions for the China market, strengthen its global leadership position in informatics, and expand its capabilities in artificial intelligence and deep learning.

    "Genomics is at the crossroads where data and biology meet," said Li Ge, chairman of WuXi NextCODE and its parent WuXi AppTec Inc.

    "Through its comprehensive capabilities for digitizing, managing and analyzing genome data, WuXi NextCODE is positioned to build an open access and capability platform that enables any organization or individual to benefit from genomic big data," he said.

    WuXi NextCODE was formed in 2015 after Shanghai-based contract research giant WuXi AppTec acquired genomic analysis firm NextCode Health, a spinoff from Reykjavik, Iceland-based Decode Genetics.

    With offices in Shanghai, Reykjavik and Cambridge in the United States, the company provides capabilities for generating, organizing, mining and applying genomic data.

    Ideally, gene sequencing can enable doctors to use a person's genome and physiology to determine the best treatments for a disease.

    To make better use of the pool of information, WuXi NextCODE announced a partnership last year with Huawei Technologies Co, China's largest telecommunications equipment maker, to enable different institutions and researchers to store their data.

    Included in the 13th Five-Year Plan (2016-20), precision medicine is predicted to be the next big thing as China moves to upgrade its healthcare landscape. By 2030, the industry expects investments to soar to approximately 60 billion yuan ($8.7 billion), according to US-based market research firm BCC Research.

    Gene research is not only an effective way to prevent birth defects and discover genetic diseases in their early stages. It can also provide drugs and treatment plans tailored to a person's unique genetic code and environmental exposure, said Xu Ruiqi, general-manager of BGI's Shanghai branch, a world-leading genome sequencer.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    欧美激情中文字幕| 亚洲成?Ⅴ人在线观看无码| 国偷自产短视频中文版| 无码国产精品一区二区免费vr| 中文字幕在线免费观看| 久久久久亚洲?V成人无码| 亚洲人成影院在线无码按摩店| 久久久久久久久久久久中文字幕| 国产精品成人无码久久久久久 | 波多野结衣中文在线播放| 国产精品无码午夜福利| 中文字幕亚洲一区二区va在线| 天堂网www中文在线| 免费VA在线观看无码| 免费无码中文字幕A级毛片| 中文字幕无码精品亚洲资源网久久| 中文字幕一区二区三区5566| 一区二区三区无码高清| 高清无码在线视频| 国产成人AV一区二区三区无码| 亚洲第一极品精品无码久久| 中文字幕日韩人妻不卡一区| 中文字幕欧美日韩| 欧美乱人伦人妻中文字幕| 亚洲日韩乱码中文无码蜜桃臀网站 | 久久精品aⅴ无码中文字字幕不卡 久久精品aⅴ无码中文字字幕重口 | 日韩精品人妻系列无码专区| 国产成人无码一区二区在线观看| 中文字幕不卡高清视频在线| 天堂中文在线资源| 中文字幕精品一区二区日本| 中文字幕免费高清视频| 亚洲成A人片在线观看中文| 色综合久久中文字幕综合网| 亚洲乱码中文字幕综合234| 无码人妻久久一区二区三区蜜桃| 中文字幕亚洲一区二区va在线| 中文字幕日韩欧美| 亚洲精品无码国产| 成人免费无码H在线观看不卡| 本免费AV无码专区一区|